Skip to main content
. 2023 Feb 2;29(2):473–482. doi: 10.1038/s41591-022-02179-2

Extended Data Fig. 1. Kaplan–Meier estimates of progression-free survival assessed by investigators in the ITT population.

Extended Data Fig. 1

Tick marks represent data censored at the time of last valid tumor assessment. Progression-free survival was assessed per the Response Evaluation Criteria in Solid Tumors version 1.1 by investigators. CF = cisplatin and 5-fluorouracil. CI = confidence interval. CPS = combined positive score. HR = hazard ratio. PD-L1 = programmed death ligand 1.